What are the considerations for extending the fusion from T10 to the pelvis with cages at L1/2 and L5/S1 in a patient with a history of L2 to L5 fusion and comorbid diabetes and hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Extension of Fusion from T10 to Pelvis with L1/2 and L5/S1 Cages

Direct Recommendation

Extending fusion from T10 to the pelvis in a patient with existing L2-L5 fusion is a high-risk procedure with 4% mortality and 35% reoperation rates, and should only be pursued if there is documented instability at the proximal (above L2) or distal (L5-S1) junctions with failed conservative management. 1

Critical Decision Framework

Primary Considerations for Extension

Proximal Extension (T10 to L2):

  • Extension above an existing fusion is indicated only when there is documented proximal junctional kyphosis (PJK) or proximal junctional failure with instability 2
  • PJK occurs in 8-48% of long fusions, with higher rates when stopping at mobile segments 2
  • The decision to extend proximally should be based on documented mechanical failure, not prophylactic concerns 2

Distal Extension (L5-S1 to Pelvis):

  • Fusion to L5 in adult deformity patients has a 50% revision rate requiring subsequent extension to the pelvis, even in carefully selected patients with less severe disability 3
  • The primary cause of revision in L5-stopped fusions is distal junctional failure (83% of revisions) 3
  • Stopping at L5 should only be considered in patients with type-N deformity (less complex), better preoperative ODI scores, and absence of severe spasticity 3, 4

Evidence Against Stopping at L5

  • In patients ≥50 years with existing long fusions, stopping at L5 results in:
    • 50% revision rate requiring extension to sacrum 3
    • Mean correction loss of lumbar lordosis of 11° (versus 3° when fused to S1) 3
    • Distal junctional failure in 5 of 6 revision cases 3

Indications for Fusion to Pelvis

Absolute indications for pelvic fixation include: 2, 5

  • Documented spondylolisthesis at L5-S1 (any grade)
  • Severe stenosis at L5-S1 requiring extensive decompression
  • Radiographic instability on flexion-extension films at L5-S1
  • Previous failed fusion stopping at L5

Relative indications include: 3

  • Age ≥50 years with existing long fusion
  • Complex deformity (non-type N classification)
  • Preoperative ODI >56
  • Pelvic obliquity >15° with spasticity 4

Technical Approach for L1/2 and L5/S1 Cages

L1/2 Cage Placement

  • An anterolateral retroperitoneal approach can safely access L1-S1 through a single incision, avoiding separate anterior approaches 6
  • Mean blood loss for multilevel anterior approach is 68±9.6 mL with this technique 6
  • This approach is muscle-splitting and psoas-preserving, reducing approach-related morbidity 6

L5/S1 Cage Placement

  • Combined anterior interbody fusion with posterior instrumentation at L5-S1 provides higher fusion rates (89-95%) and better biomechanical stability than posterolateral fusion alone 7, 2
  • The anterior approach at L5-S1 improves disc height restoration and foraminal decompression 7
  • L5-S1 is technically accessible through the anterolateral approach without requiring separate direct anterior exposure 6

Risk Stratification for T10-Pelvis Fusion

Mortality and Major Complications

  • 4% mortality rate for thoracic-to-pelvis fusions in adults 1
  • 12% experience at least one major medical complication 1
  • 17% develop new persistent neurologic deficits 1
  • 35% require at least one unplanned return to operating room 1

Risk Factors for Complications

  • Major medical complications correlate with ASA score (p=0.030) and Charlson Comorbidity Index (p=0.028) 1
  • Diabetes and hypertension increase perioperative risk and warrant extended postoperative monitoring 2
  • Mean hospital stay is 12±7 days with mean ICU stay of 2.7±4 days 1
  • 58% of patients require discharge to rehabilitation facility 1

Algorithm for Decision-Making

Step 1: Assess Need for Proximal Extension

  • Obtain flexion-extension radiographs of thoracolumbar junction
  • Document PJK or proximal junctional failure
  • If no documented instability above L2, proximal extension is NOT indicated 2, 5

Step 2: Assess Need for Distal Extension to Pelvis

  • If patient is ≥50 years with existing long fusion, strongly consider extending to pelvis given 50% revision rate when stopping at L5 3
  • Obtain flexion-extension radiographs of L5-S1
  • Document any degree of spondylolisthesis at L5-S1 (absolute indication for fusion) 2, 5
  • Assess L5-S1 disc degeneration and stenosis severity
  • If moderate-to-severe stenosis or any instability at L5-S1, extend to pelvis 2, 5

Step 3: Conservative Management Documentation

  • Verify 3-6 months of comprehensive conservative management including formal physical therapy 2
  • Document failed epidural steroid injections, medications, and other modalities 2

Step 4: Surgical Planning

  • Use anterolateral retroperitoneal approach for L1/2 and L5/S1 cage placement 6
  • Plan combined anterior-posterior approach at L5-S1 for optimal fusion rates 7
  • Extend to pelvis with iliac fixation if proceeding with L5-S1 fusion 3

Critical Pitfalls to Avoid

  • Do not stop fusion at L5 in patients ≥50 years with existing long fusions—50% will require revision to pelvis 3
  • Do not extend fusion proximally without documented PJK or instability 2
  • Do not perform L5-S1 fusion without extending to pelvis in the setting of existing long fusion 3
  • Do not underestimate surgical risk—this is a high-morbidity procedure requiring ICU monitoring 1
  • Avoid prophylactic extension without documented mechanical failure or instability 2, 5

Expected Outcomes

If fusion extended to pelvis: 3

  • Correction loss of lumbar lordosis: 3° (versus 11° when stopped at L5)
  • Revision rate: 14% (versus 50% when stopped at L5)
  • PJK rate: 48% (versus 8% when stopped at L5, but with higher distal failure)

Clinical improvement: 6

  • VAS Back Pain improves from 7.5 preoperatively to 1.4 at 1 year (p=0.02)
  • ODI improves from 64.3 to 6.7 at 1 year (p=0.01)

References

Guideline

Medical Necessity of Lumbar Fusion

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

The indication of fusion to the pelvis in neuromuscular scoliosis is based on the underlying disease rather than on pelvic obliquity.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2023

Guideline

Lumbar Spine Fusion for Spinal Stenosis with Neurogenic Claudication

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Medical Necessity of L5-S1 Anterior Interbody Fusion with Posterior Instrumentation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.